Double-blind comparative prospective clinical evaluation of a combination antispasmodic--Manyana (R) (diclofenac pitafenone and fenpeverinium) and Baralgan (analgin + pitafenone and fenpeverinium) in intestinal, biliary and ureteric colic.
Chaudhary
A
A
Department of G.I. Surgery, GB Pant Hospital, New Delhi.
Gupta
R L
RL
D000293:Adolescent; D000328:Adult; D001577:Benzophenones / Q000627:therapeutic use*; D001660:Biliary Tract Diseases / Q000175:diagnosis / Q000188:drug therapy*; D003085:Colic / Q000175:diagnosis / Q000188:drug therapy*; D004008:Diclofenac / Q000627:therapeutic use*; D004177:Dipyrone / Q000627:therapeutic use*; D004311:Double-Blind Method; D004338:Drug Combinations; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007410:Intestinal Diseases / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010276:Parasympatholytics / Q000627:therapeutic use*; D010880:Piperidines / Q000627:therapeutic use*; D011446:Prospective Studies; D016896:Treatment Outcome; D014515:Ureteral Diseases / Q000175:diagnosis / Q000188:drug therapy*
D001577:Benzophenones; D004338:Drug Combinations; D010276:Parasympatholytics; D010880:Piperidines; C118979:manyana; D004008:Diclofenac; D004177:Dipyrone; C002416:fenpiverinium bromide, pitofenone hydrochloride, dipyrone drug combination